Pensa Pharma

Pensa Pharma is a specialized pharmaceutical company focused on the development, manufacturing, and commercialization of generic medicines. Headquartered in Martorelles, Spain, the company was originally established as the generic division of the Esteve Group before being acquired by the Japanese firm Towa Pharmaceutical in 2020. Pensa Pharma maintains a robust portfolio of high-quality generic products across therapeutic areas such as cardiovascular health, gastroenterology, and the central nervous system. The company operates a large-scale, GMP-certified manufacturing facility that serves as a strategic production hub for the European and international markets. Through its integration with Towa, Pensa Pharma continues to expand its reach, providing affordable healthcare solutions and value-added medicines globally.